Investor Relations

Press Releases

Date Title  
Toggle Summary JPLs release copy of their Tenth Report to the Grand Court of the Caymans Islands
Toggle Summary JPLs release copy of their Ninth Report to the Grand Court of the Caymans Islands
Toggle Summary The JPLs summons (as amended) was part-heard on 30 July 2024 and resulted in various orders by the Grand Court of the Cayman Islands. On 9 August 2024, a notice was issued to shareholders providing, inter alia, details of the outcome of the hearing, together with a copy of the Court orders.
Toggle Summary On 18 July 2024, the JPLs issued correspondence to shareholders providing notice of an amendment to the Summons to seek Court approval of the proposed terms of remuneration. A sealed version of the amended summons was received from the Court Registry on 17 July 2024. Please click here for a copy of the notice and the Court orders
Toggle Summary JPLs release copy of their Eighth Report to the Grand Court of the Cayman Islands
Toggle Summary i. On 13 May 2024, the JPLs filed a summons for court approval of the terms of their remuneration agreement and their remuneration for the Fee Approval Period pursuant to section 109(2) of the Companies Act and the Insolvency Practitioners' Regulations (2023 Consolidation) (the "Summons"). The Summons has been listed for hearing at 10am on 30 July 2024.
ii. Any shareholder who wishes to provide any additional comments or queries regarding the JPLs' proposed terms of remuneration and the JPLs' remuneration for the Fee Approval Period should do so in writing to the JPLs by no later than 1 July 2024. Any communications should be sent by email to [email protected].
iii. Any shareholder who intends to appear at the hearing of the Summons must notify the JPLs and confirm whether they support or oppose the orders being sought by no later than 9 July 2024 so as to ensure that the hearing of the Summons proceeds in an orderly manner.
Toggle Summary JPL's announce EGM to be held on 16 April 2024 for the purpose of considering and, if thought fit, passing resolutions in respect to the JPL's proposed terms of remuneration and the JPL's remuneration and disbursements for the period from 22 September 2022 to 30 September 2023. Further details regarding the proposals are set out in the i) Notice of EGM ii) Proxy Card iii) Proxy Statement and iv) Rules of Conduct. Note that only verified shareholders will be able to vote at the EGM.
Toggle Summary JPLs release copy of their Seventh Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their Sixth Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their Fifth Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their Fourth Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their Third Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their Second Report to the Grand Court of the Cayman Islands
Toggle Summary JPLs release copy of their First Report to the Grand Court of the Cayman Islands
Toggle Summary Press Release in respect of the JPLs appointment
Toggle Summary Global Cord Blood Corporation Files Annual Report on Form 20-F
Toggle Summary Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Toggle Summary Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
Toggle Summary Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
Toggle Summary Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
Toggle Summary Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
Toggle Summary Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
Toggle Summary Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal
Toggle Summary Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022
Toggle Summary Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2022 Financial Results
Toggle Summary Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022
Toggle Summary Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results
Toggle Summary Global Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021
Toggle Summary Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
Toggle Summary Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
Toggle Summary Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021
Toggle Summary Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2021 Financial Results
Toggle Summary Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal
Toggle Summary Global Cord Blood Announces NHC Policy Update
Toggle Summary Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021
Toggle Summary Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results
Toggle Summary Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021
Toggle Summary Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
Toggle Summary Global Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020
Toggle Summary Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results
Toggle Summary Global Cord Blood Corporation Provides Further Update on COVID-19
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
Toggle Summary Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results
Toggle Summary Global Cord Blood Corporation Provides Update on Impact of Coronavirus
Toggle Summary Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
Toggle Summary PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided
Toggle Summary Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020
Toggle Summary Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
Toggle Summary Global Cord Blood Corp Comments on New Regulation
Toggle Summary Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director
Toggle Summary Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
Toggle Summary Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results
Toggle Summary Global Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019
Toggle Summary Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results
Toggle Summary Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
Toggle Summary Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
Toggle Summary Global Cord Blood Corporation Raised Subscription Fee
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019
Toggle Summary Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results
Toggle Summary Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2019
Toggle Summary Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results
Toggle Summary Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2019
Toggle Summary Global Cord Blood Corporation Announces the Results of Scrip Dividend Elections
Toggle Summary Global Cord Blood Corporation to Report First Quarter Fiscal 2019 Financial Results
Toggle Summary Global Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
Toggle Summary Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2018 Financial Results
Toggle Summary China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to “Global Cord Blood Corporation”
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results
Toggle Summary China Cord Blood Corporation to Change Corporate Name to “Global Cord Blood Corporation”
Toggle Summary Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation
Toggle Summary China Cord Blood Corporation Announces Results of 2017 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2018 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017
Toggle Summary China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2018
Toggle Summary China Cord Blood Corporation to Report First Quarter Fiscal 2018 Financial Results
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2017 Financial Results
Toggle Summary China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding “Going Private” Proposal
Toggle Summary China Cord Blood Corporation Receives Notification of Exercise of 7% Senior Convertible Notes
Toggle Summary China Cord Blood Corporation Announces Executive Change
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2017 Financial Results
Toggle Summary China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement
Toggle Summary China Cord Blood Corporation Announces Results of 2016 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2017
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2017 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 9, 2016
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2017
Toggle Summary China Cord Blood Corporation to Report First Quarter of Fiscal 2017 Financial Results
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results
Toggle Summary China Cord Blood Corporation Announces Results of 2015 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2016
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2016 Financial Results
Toggle Summary China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited by American Association of Blood Banks
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 10, 2015
Toggle Summary China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2016
Toggle Summary China Cord Blood Corporation to Report First Quarter of Fiscal 2016 Financial Results
Toggle Summary China Cord Blood Corporation Announces Receipt of Non-Binding Acquisition Proposal
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2015
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2015 Financial Results
Toggle Summary China Cord Blood Corporation’s Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding “Going Private” Proposal
Toggle Summary China Cord Blood Corporation Announces Resignation of an Independent Director
Toggle Summary China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife
Toggle Summary China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR
Toggle Summary China Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
Toggle Summary China Cord Blood Corporation Announces Receipt of “Going Private” Proposal
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2015 Financial Results
Toggle Summary China Cord Blood Corporation and Cord Blood Registry Enter into Strategic Collaboration
Toggle Summary China Cord Blood Corporation Announces Results of 2014 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2015 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014
Toggle Summary China Cord Blood Corporation to Incentivize Management Team with Share Awards
Toggle Summary China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results
Toggle Summary China Cord Blood Corporation Receives Notice of Transaction Regarding its 7% Senior Convertible Note Due 2017 Held by Golden Meditech
Toggle Summary China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2014
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2014 Financial Results
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2014
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2014 Financial Results
Toggle Summary China Cord Blood Corporation Announces Results of 2013 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2014 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 16, 2013
Toggle Summary China Cord Blood Corporation Announces Resignation of Director
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2014
Toggle Summary China Cord Blood Corporation to Report First Quarter of Fiscal 2014 Financial Results
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
Toggle Summary China Cord Blood Corporation’s Beijing Subsidiary Received AABB Accreditation
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
Toggle Summary China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
Toggle Summary China Cord Blood Corporation Announces Participation in the 31st Annual J.P. Morgan Healthcare Conference
Toggle Summary China Cord Blood Corporation Announces Results of 2012 Annual General Meeting
Toggle Summary China Cord Blood Corporation to Further Consolidate its Corporate Structure
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
Toggle Summary China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2012
Toggle Summary China Cord Blood Corporation Continues Share Repurchase Program
Toggle Summary China Cord Blood Corporation Announces Completion of $50 Million Convertible Note Financing with Golden Meditech
Toggle Summary China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013
Toggle Summary China Cord Blood Corporation to Report First Quarter of Fiscal 2013 Financial Results
Toggle Summary China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
Toggle Summary China Cord Blood Corporation Files its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Continues Share Repurchase Program
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2012 Financial Results
Toggle Summary China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR
Toggle Summary China Cord Blood Corporation Announces Investment by KKR
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
Toggle Summary China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2012 Financial Results
Toggle Summary China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2012
Toggle Summary China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F
Toggle Summary China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences
Toggle Summary China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012
Toggle Summary China Cord Blood Corporation to Report First Quarter Fiscal 2012 Financial Results
Toggle Summary China Cord Blood Corporation Continues Share Repurchase Program
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
Toggle Summary China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation Forms Zhejiang Subsidiary
Toggle Summary China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
Toggle Summary China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
Toggle Summary China Cord Blood Corporation Announces Completion of Warrant Exchange
Toggle Summary China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
Toggle Summary China Cord Blood Corporation Reports Second Quarter and First Half Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation to Announce Second Quarter Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation Commences Warrant Exchange Offer
Toggle Summary China Cord Blood Corporation Announces Pricing of Follow-On Public Offering of Ordinary Shares
Toggle Summary China Cord Blood Corporation Announces Proposed Public Offering of Ordinary Shares
Toggle Summary China Cord Blood Corporation Files Its Annual Report on Form 20-F/A
Toggle Summary China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
Toggle Summary China Cord Blood Corporation Announces Mandate for Share Repurchase Program
Toggle Summary China Cord Blood Corporation Announces Framework Agreement Regarding Fourth License - Zhejiang Province
Toggle Summary China Cord Blood Corporation to Launch Warrant Exchange Offer
Toggle Summary China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results
Toggle Summary China Cord Blood Corporation Increases Ownership Stake in Cordlife
Toggle Summary China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
Toggle Summary China Cord Blood Corporation Continuous Support For Cordlife Rights Issue
Toggle Summary China Cord Blood Corporation Joins Russell Global Index
Toggle Summary China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010
Toggle Summary China Cord Blood Corporation To Announce Fourth Quarter & Fiscal Year 2010 Financial Results; Earnings Call Scheduled for June 22, 2010
Toggle Summary China Cord Blood Corporation Enhances Presence in Greater Asia Region
Toggle Summary China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010
Toggle Summary China Cord Blood Corporation To Announce Third Quarter Fiscal 2010 Earnings Results; Earnings Call Scheduled for March 5, 2010
Toggle Summary China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank
Toggle Summary China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
Toggle Summary China Cord Blood Corporation Announces Full Exercise of Over-Allotment Option
Toggle Summary China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option
Toggle Summary China Cord Blood Corporation Announces Results For The Quarter and Six Months Ended September 30, 2009
Toggle Summary China Cord Blood Corporation To Announce Second Quarter Fiscal 2010 Earnings Results
Toggle Summary China Cord Blood Corporation Announces Listing on NYSE and Pricing of Secondary Public Offering

About GCBC

Services

Investor Relations

About Cord Blood Banking

Copyright © 2022 Global Cord Blood Corporation. All rights reserved.
Sitemap     |    Terms of Use